HUMANWELL PURACAP PHARMACEUTICALS (WUHAN) CO., LTD. v. APICORE US LLC

CourtDistrict Court, D. New Jersey
DecidedAugust 15, 2025
Docket3:24-cv-08938
StatusUnknown

This text of HUMANWELL PURACAP PHARMACEUTICALS (WUHAN) CO., LTD. v. APICORE US LLC (HUMANWELL PURACAP PHARMACEUTICALS (WUHAN) CO., LTD. v. APICORE US LLC) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
HUMANWELL PURACAP PHARMACEUTICALS (WUHAN) CO., LTD. v. APICORE US LLC, (D.N.J. 2025).

Opinion

DISTRICT OF NEW JERSEY

CHAMBERS OF U.S. COURTHOUSE ZAHID N. QURAISHI 402 EAST STATE STREET, ROOM 4000 UNITED STATES DISTRICT JUDGE TRENTON, NJ 08608

August 15, 2025

LETTER OPINION

Re: HUMANWELL PURACAP PHARMACEUTICALS (WUHAN) CO., LTD., v. APICORE US LLC, et al., Civil Action No. 24-8938 (ZNQ) (TJB)

Dear Counsel:

THIS MATTER comes before the Court upon a Motion for Default Judgment filed by Plaintiff Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd. (“Plaintiff”). (“Motion,” ECF No. 10.) Plaintiff filed a Moving Brief in support of the Motion (“Moving Br.,” ECF No. 10-1), a declaration by Wen Jiao, the purchasing supervisor at Plaintiff (“Jiao Decl.,” ECF No. 10-2), copies of the purchase contracts and invoices at issue (ECF No. 10-2), and an affidavit by counsel Jing Xia (“Xia Aff.,” ECF No. 10-3). After careful consideration of Plaintiff’s submissions, the Court decides the Motion without oral argument pursuant to Federal Rule of Civil Procedure 78 and Local Civil Rule 78.1.1 For the reasons set forth below, the Court will GRANT Plaintiff’s Motion for Default Judgment.

I. BACKGROUND

The facts in this case are relatively straightforward. Plaintiff entered into two contracts with Apicore US LLC (“Apicore”) related to Plaintiff’s purchase of 15 kgs of Bexarotene: one contract for 6.5 kgs and another contract for the remaining 8.5 kgs. (Xia Aff. ¶ 2.) Plaintiff paid $248,750.00 for the Bexarotene but never received it. (Id. ¶¶ 3, 4.) As a result, on September 3, 2024, Plaintiff commenced the instant civil action, stating claims against Apicore and its subsidiary, RK Pharma Inc. (“Defendants”) for: 1) breach of contract for the failure to deliver the 6.5 kgs of Bexarotene; 2) breach of contract for the failure to deliver and ship the 8.5 kgs of Bexarotene; 3) unjust enrichment; 4) promissory estoppel; and 5) money had and received. (See generally “Compl.,” ECF No. 1.)

On September 6, 2024, Defendants’ registered agents were properly served with process as reflected on the docket by the proof of service filed on September 13, 2024. (ECF Nos. 3, 4;

1 Hereinafter, all references to “Rule” or “Rules” refer to the Federal Rules of Civil Procedure unless otherwise noted. 1 Xia Aff. ¶ 7.) The time for answering the Complaint expired, and Defendants were not granted an extension of time within which to answer. Defendants have failed to file an answer or otherwise respond to the Complaint.

On October 1, 2024, Plaintiff sought a Clerk’s entry of default which they received one day later. (ECF No. 7.) Thereafter, the Court entered a notice of call for dismissal (ECF No. 8) which triggered the filing of the instant Motion for Default Judgment. (ECF No. 10.) On January 31, 2025, Plaintiff filed proof of service of the Motion on Defendants. (ECF No. 11.) To date, Defendants have not responded to Plaintiff’s Motion.

II. DISCUSSION

A. Jurisdiction

The Court has subject matter jurisdiction over the claims in the Complaint pursuant to 28 U.S.C. § 1332. (See ECF Nos. 5, 6; see also ECF No. 10-2.) Plaintiff is a publicly held Chinese company, Defendants are citizens of Delaware who do business in New Jersey and New York, and Plaintiff seeks damages greater than $75,000. (See ECF No. 10-3; see also Compl.)

The Court also has specific personal jurisdiction over Defendants because the contracts at issue state that the seller’s shipping address is in New Jersey, and therefore Defendants can “anticipate being haled” into court in New Jersey. See World-Wide Volkswagen Corp. v. Woodson, 444 U.S. 286, 297 (1980). Moreover, by doing business in New Jersey, Defendants are purposefully availing themselves of the privileges of the forum state. Vetrotex Certainteed Corp. v. Consol. Fiber Glass Prods. Co., 75 F.3d 147, 151 (3d Cir. 1996); Hanson v. Denckla, 357 U.S. 235, 253 (1958). Lastly, Plaintiff’s contractual injuries arise out of or relate to Defendants’ purposeful conduct in New Jersey, and exercising jurisdiction over them does not “offend traditional notions of fair play and substantial justice.” See International Shoe, Co. v. Washington, 326 U.S. 310, 316 (1945).

B. Default Judgment

Rule 55 governs default and default judgment. See Fed. R. Civ. P. 55. Pursuant to the Rule, the clerk must enter default against a party who “has failed to plead or otherwise defend, and that failure is shown by affidavit or otherwise.” Fed. R. Civ. P. 55(a). After an entry of default, a plaintiff may seek default judgment under either Rule 55(b)(1) or Rule 55(b)(2). Doug Brady, Inc. v. N.J. Bldg. Laborers Statewide Funds, 250 F.R.D. 171, 177 (D.N.J. 2008); see also Nationwide Mut. Ins. Co. v. Starlight Ballroom Dance Club, Inc., 175 F. App’x 519, 521 n.1 (3d Cir. 2006) (“Prior to obtaining a default judgment under either Rule 55(b)(1) or Rule 55(b)(2), there must be entry of default as provided by Rule 55(a).”). Here, Plaintiff seeks default judgment under Rule 55(b)(2).

2 “It is well settled in this Circuit that the entry of a default judgment is left primarily to the discretion of the district court.” Hritz v. Woma Corp., 732 F.2d 1178, 1180 (3d Cir. 1984). However, “entry of default judgments is disfavored as decisions on the merits are preferred.” Animal Sci. Prods., Inc. v. China Nat’l Metals & Minerals Imp. & Exp. Corp., 596 F. Supp. 2d 842, 848 (D.N.J. 2008) (citing Super 8 Motels, Inc. v. Kumar, Civ. No. 06-5231, 2008 WL 878426, at *3 (D.N.J. Apr. 1, 2008)). In other words, the district court must remain mindful that entry of default “is a sanction of last resort.” Id.

“In assessing whether the entry of default judgment is warranted, the court utilizes a three- step analysis, under which the Court must determine (1) whether there is sufficient proof of service[;] (2) whether a sufficient cause of action was stated[;] and (3) whether default judgment is proper[.]” Paniagua Grp., Inc. v. Hosp. Specialists, LLC, 183 F. Supp. 3d 591, 599–600 (D.N.J. 2016) (internal quotation marks omitted).

First, as already articulated, the Court finds that there was sufficient proof of service because Plaintiff personally served Defendants via their agents. (ECF Nos. 3, 4; Xia Aff. ¶ 7.)

Second, the Court finds that Plaintiff has stated sufficient causes of action. Plaintiff alleges claims for breach of contract and provides the Court with those contracts. “A consequence of the entry of a default judgment is that the factual allegations of the complaint . . . will be taken as true.” Comdyne I, Inc. v. Corbin, 908 F.2d 1142, 1149 (3d Cir.1990) (citation and quotation marks omitted).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

International Shoe Co. v. Washington
326 U.S. 310 (Supreme Court, 1945)
Hanson v. Denckla
357 U.S. 235 (Supreme Court, 1958)
World-Wide Volkswagen Corp. v. Woodson
444 U.S. 286 (Supreme Court, 1980)
Comdyne I, Inc. v. Corbin
908 F.2d 1142 (Third Circuit, 1990)
Dunn v. HOVIC
13 F.3d 58 (Third Circuit, 1993)
Litton Industries, Inc. v. IMO Industries, Inc.
982 A.2d 420 (Supreme Court of New Jersey, 2009)
County of Essex v. First Union National Bank
891 A.2d 600 (Supreme Court of New Jersey, 2006)
Hritz v. Woma Corp.
732 F.2d 1178 (Third Circuit, 1984)

Cite This Page — Counsel Stack

Bluebook (online)
HUMANWELL PURACAP PHARMACEUTICALS (WUHAN) CO., LTD. v. APICORE US LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/humanwell-puracap-pharmaceuticals-wuhan-co-ltd-v-apicore-us-llc-njd-2025.